UPDATE: Galectin (GALT) Gets U.S. Patent for Carb-Based Galectin Inhibitor; Shares Volatile
Tweet Send to a Friend
(Updated - July 23, 2012 9:58 AM EDT)
Galectin Therapeutics (Nasdaq: GALT) shares have been paused for volatility Monday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Galectin Therapeutics (Nasdaq: GALT) shares have been paused for volatility Monday ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
